Xilio Therapeutics Statistics

Total Valuation

XLO has a market cap or net worth of $37.28 million. The enterprise value is $3.49 million.

Market Cap	37.28M
Enterprise Value	3.49M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, before market open.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

XLO has 36.91 million shares outstanding. The number of shares has increased by 0.38% in one year.

Shares Outstanding	36.91M
Shares Change (YoY)	+0.38%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	31.90%
Owned by Institutions (%)	49.46%
Float	16.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.01
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.34.

Current Ratio	3.02
Quick Ratio	n/a
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -126.60% and return on invested capital (ROIC) is -160.41%.

Return on Equity (ROE)	-126.60%
Return on Assets (ROA)	-89.20%
Return on Capital (ROIC)	-160.41%
Revenue Per Employee	n/a
Profits Per Employee	-$1.05M
Employee Count	73
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.83% in the last 52 weeks. The beta is -0.08, so XLO's price volatility has been lower than the market average.

Beta (1Y)	-0.08
52-Week Price Change	-68.83%
50-Day Moving Average	0.90
200-Day Moving Average	1.53
Relative Strength Index (RSI)	46.37
Average Volume (30 Days)	1,224,311

Short Selling Information

The latest short interest is 379,490, so 1.03% of the outstanding shares have been sold short.

Short Interest	379,490
Short Previous Month	54,237
Short % of Shares Out	1.03%
Short % of Float	2.31%
Short Ratio (days to cover)	0.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-79.13M
Pretax Income	-76.40M
Net Income	-76.40M
EBITDA	-74.50M
EBIT	-76.40M
Earnings Per Share (EPS)	-$2.78

Full Income Statement

Balance Sheet

The company has $46.29 million in cash and $12.50 million in debt, giving a net cash position of $33.79 million or $0.92 per share.

Cash & Cash Equivalents	46.29M
Total Debt	12.50M
Net Cash	33.79M
Net Cash Per Share	$0.92
Equity / Book Value	36.83M
Book Value Per Share	1.00
Working Capital	32.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.62 million and capital expenditures -$486,000, giving a free cash flow of -$69.11 million.

Operating Cash Flow	-68.62M
Capital Expenditures	-486,000
Free Cash Flow	-69.11M
FCF Per Share	-$2.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.38%
Shareholder Yield	-0.38%
Earnings Yield	-204.94%
FCF Yield	-185.36%

Analyst Forecast

The average price target for XLO is $7.00, which is 593.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	593.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2